Targeting the inflammasome with the selective small-molecule inhibitor MCC950 suppressed infiltration with immune cells in NASH caused by overnutrition in atherogenic diet-fed foz/foz mouse model alongside decreased IL-1β, IL-6, and MCP-1 levels (143). Here, IL1B is linked to metabolic dysfunction-associated steatohepatitis.